Stefan Grass News Today

Medtech company Bactiguard has developed a thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices.

The VITAL study, by Professor Pierre Damas and his team, is now published in the well renowned journal Annals of Intensive Care. The study shows a 53% reduction of ventilator-associated pneumonia with Bactiguard’s endotracheal tube. It was presented for the first time at the European Society of Intensive Care congress (ESICM) in October 2021.

/PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well renowned journal Annals of Intensive Care. The study...

/PRNewswire/ -- This week at the European Society of Intensive Care congress (ESICM), a study from Liège, Belgium on Bactiguards endotracheal tubes was...

A large randomized clinical trial shows significant reduction in urinary tract infections News provided by Share this article STOCKHOLM, March 11, 2021 /PRNewswire/ -- A recently published, randomized, controlled multicenter study in India shows that urinary catheters with Bactiguards coating for infection prevention reduce the risk of catheter-associated urinary tract infections (CAUTI) by 69% compared to standard catheters. "We are very proud to be able to present such fine results from the...

 , Feb. 9, 2021 /PRNewswire/ -- Health Canada has approved Bactiguards urinary catheter with temperature sensor for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguards catheters can reduce the risk of secondary infections for critically ill patients. "Many critically ill COVID-19 patients require a urinary catheter with integrated temperature monitoring. The ICU treatment period can be 14 days or more, which means patients will require an indwelli...